Questcor (QCOR -6%) gets hit today after Blue Cross/Blue Shield of Michigan denies coverage of...

|By:, SA News Editor

Questcor (QCOR -6%) gets hit today after Blue Cross/Blue Shield of Michigan denies coverage of it's Acthar Gel for steroid-responsive conditions, saying the clinical need has not been demonstrated. Coverage will continue to be provided however, for treatment of infantile spasms, which is one of its FDA approved indications.